Literature DB >> 22554718

Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada.

Jeffrey Perl1, Ron Wald, Joanne M Bargman, Yingbo Na, S Vanita Jassal, Arsh K Jain, Louise Moist, Sharon J Nessim.   

Abstract

BACKGROUND AND OBJECTIVES: In the last 15 years in Canada, there have been less stringent guidelines for peritoneal dialysis (PD) adequacy, availability of novel PD solutions, and lower PD-related peritonitis rates. Effects of these changes on outcomes of incident patients treated with PD during this period are unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Risk of PD technique failure and mortality were compared among three incident cohorts of PD patients who initiated dialysis during the following periods: 1995-2000, 2001-2005, and 2006-2009. A multivariable model was used to evaluate time to PD technique failure using inverse probability of treatment and censoring weights accounting for changing survival and transplantation rates.
RESULTS: Between 1995 and 2009,13,120 incident adult PD patients were identified from the Canadian Organ Replacement Register. Compared with the 1995-2000 cohort (n=5183), the risk of PD technique failure was lower among patients between 2001 and 2005 (n=4316) but similar among incident patients between 2006 and 2009 (n=3621). Cause-specific PD technique failure revealed no difference in PD peritonitis-related technique failure over time. PD technique failure due to inadequate PD was initially higher in the 2001-2005 cohort but lower in the 2006-2009 cohort compared with the 1995-2000 cohort. Relative to incident patients between 1995 and 2000, adjusted mortality was lower among incident patients between 2001 and 2005 and 2006 and 2009.
CONCLUSIONS: Survival on PD continues to improve with only modest changes in PD technique failure. Peritonitis remains an ongoing and modifiable source of PD technique failure.

Entities:  

Mesh:

Year:  2012        PMID: 22554718      PMCID: PMC3386671          DOI: 10.2215/CJN.01480212

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  39 in total

1.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality.

Authors:  Wai H Lim; Gursharan K Dogra; Stephen P McDonald; Fiona G Brown; David W Johnson
Journal:  Perit Dial Int       Date:  2011-05-31       Impact factor: 1.756

3.  APD in the elderly.

Authors:  Pradeep Kadambi; Laura Troidle; Nancy Gorban-Brennan; Alan S Kliger; Fredric O Finkelstein
Journal:  Semin Dial       Date:  2002 Nov-Dec       Impact factor: 3.455

4.  Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis.

Authors:  D E Schaubel; P G Blake; S S Fenton
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

5.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

6.  Adapting the Charlson Comorbidity Index for use in patients with ESRD.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Hude Quan; William A Ghali
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

7.  Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study.

Authors:  Wai-Kei Lo; Yiu-Wing Ho; Chun-Sang Li; Kin-Shing Wong; Tak-Mao Chan; Alex Wai-Yin Yu; Flora So-King Ng; Ignatius Kum-Po Cheng
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

8.  Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.

Authors:  Helen Lee; Braden Manns; Ken Taub; William A Ghali; Stafford Dean; David Johnson; Cam Donaldson
Journal:  Am J Kidney Dis       Date:  2002-09       Impact factor: 8.860

9.  Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.

Authors:  Edwina A Brown; Simon J Davies; Peter Rutherford; Frederique Meeus; Mercedes Borras; Werner Riegel; Jose C Divino Filho; Edward Vonesh; Monique van Bree
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

10.  Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.

Authors:  Simon J Davies; Graham Woodrow; Kieron Donovan; Jörg Plum; Paul Williams; Ann Catherine Johansson; Hans-Peter Bosselmann; Olof Heimbürger; Ole Simonsen; Andrew Davenport; Anders Tranaeus; Jose C Divino Filho
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

View more
  30 in total

1.  Translating an understanding of the determinants of technique failure to maximize patient time on peritoneal dialysis?

Authors:  Rajnish Mehrotra
Journal:  Perit Dial Int       Date:  2013 Mar-Apr       Impact factor: 1.756

2.  Risk factors for drainage-requiring ascites after refractory peritonitis in peritoneal dialysis patients.

Authors:  Cheng-Chia Lee; Kun-Hua Tu; Hsiao-Hui Chen; Ming-Yang Chang; Cheng-Chieh Hung
Journal:  Int Urol Nephrol       Date:  2016-08-05       Impact factor: 2.370

3.  Gastroscopy-related peritonitis in peritoneal dialysis patients.

Authors:  Annie-Claire Nadeau-Fredette; Joanne M Bargman
Journal:  Perit Dial Int       Date:  2014 Sep-Oct       Impact factor: 1.756

4.  Novel predictors of peritonitis-related outcomes in the BRAZPD cohort.

Authors:  Thyago Proença de Moraes; Marcia Olandoski; Jaqueline C T Caramori; Luis C Martin; Natália Fernandes; José Carolino Divino-Filho; Roberto Pecoits-Filho; Pasqual Barretti
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

Review 5.  Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative.

Authors:  Christopher Chan; Gill Combes; Simon Davies; Fred Finkelstein; Catherine Firanek; Rafael Gomez; Kitty J Jager; Vivek Jha George; David W Johnson; Mark Lambie; Magdalena Madero; Ikuto Masakane; Stephen McDonald; Madhukar Misra; Sandip Mitra; Thyago Moraes; Annie-Claire Nadeau-Fredette; Purna Mukhopadhyay; Jeff Perl; Ronald Pisoni; Bruce Robinson; Dong-Ryeol Ryu; Rajiv Saran; James Sloand; Nidhi Sukul; Allison Tong; Cheuk-Chun Szeto; Wim Van Biesen
Journal:  Perit Dial Int       Date:  2019 Jan-Feb       Impact factor: 1.756

Review 6.  Peritoneal Dialysis in Western Countries.

Authors:  Dirk G Struijk
Journal:  Kidney Dis (Basel)       Date:  2015-09-03

7.  Functional Disability in Older Adults Maintained on Peritoneal Dialysis Therapy.

Authors:  Ozkan Ulutas; Janine Farragher; Ernest Chiu; Wendy L Cook; Sarbjit V Jassal
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

8.  The risk factors and the impact of hernia development on technique survival in peritoneal dialysis patients: a population-based cohort study.

Authors:  Shang-Feng Yang; Chia-Jen Liu; Wu-Chang Yang; Chao-Fu Chang; Chih-Yu Yang; Szu-Yuan Li; Chih-Ching Lin
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

9.  The impact of transfer from hemodialysis on peritoneal dialysis technique survival.

Authors:  Sharon J Nessim; Joanne M Bargman; S Vanita Jassal; Matthew J Oliver; Yingbo Na; Jeffrey Perl
Journal:  Perit Dial Int       Date:  2013-12-01       Impact factor: 1.756

10.  Viridans streptococci in peritoneal dialysis peritonitis: clinical courses and long-term outcomes.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Wei-Shun Yang; Huei-Wen Chen; Cheng-Chung Fang; Chung-Jen Yen; Chih-Kang Chiang; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.